OncohematologyOncohematologyОнкогематология1818-83462413-4023Publishing House ABV Press2810.17650/1818-8346-2013-8-3-60-68BASIC RESEARCHФУНДАМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ В ПРАКТИЧЕСКОЙ МЕДИЦИНЕ НА СОВРЕМЕННОМ ЭТАПЕPlatelet antigens and antibodies. Literature reviewАнтигены и антитела к тромбоцитам (обзор литературы)MineevaN. V.МинееваН. В.
Russian Federation
KrobinetsI. I.КробинецИ. И.
Russian Federation
irina_laborant@mail.ruBlinovM. N.БлиновМ. Н.
Russian Federation
KapustinS. I.КапустинС. И.
Russian Federation
Russian Research Institution of Hematology and Transfusiology, Federal Medical and Biological AgencyФГБУ «Российский научно-исследовательский институт гематологии и трансфузиологии» ФМБА России2108201383606821072014210720142013https://oncohematology.abvpress.ru/ongm/article/view/28

Platelet antigens structure, role of platelet antibodies in the pathogenesis of various clinical conditions, characteristic of modern antibodies detection methods are presented in this article.

В статье представлен обзор литературы о строении антигенов тромбоцитов, показана роль тромбоцитарных антител в патогенезе различных клинических состояний, дана характеристика современных методов выявления антител.

plateletsantigensalloantibodiesautoantibodiesneonatal thrombocytopeniaalloimmunizationHLAplatelet transfusionrefractoryтромбоцитыантигеныаллоантителааутоантителатромбоцитопения новорожденногоаллоиммунизацияHLAтрансфузии тромбоцитоврефрактерность1. Norton A., Allen D., Murphy M. Review: Platelet alloantigen and antibodies and their clinical significance. Immunohematology 2004;20(2):89–102.Norton A., Allen D., Murphy M. Review: Platelet alloantigen and antibodies and their clinical significance. Immunohematology 2004;20(2):89–102.2. Зотиков Е.А., Бабаева А.Г., Головкина Л.Л. Тромбоциты и антитромбоцитарные антитела. М.: Монолит, 2003. 128 с.Зотиков Е.А., Бабаева А.Г., Головкина Л.Л. Тромбоциты и антитромбоцитарные антитела. М.: Монолит, 2003. 128 с.3. Transfusion and transplantation science (Fundamentals of biomedical science). Editor R. Knight. Oxford, 2012. 304 p.Transfusion and transplantation science (Fundamentals of biomedical science). Editor R. Knight. Oxford, 2012. 304 p.4. Murphy M., Pamphilon D. Practical Transfusion Medicine. Wiley-Blackwell, 2013. 549 p.Murphy M., Pamphilon D. Practical Transfusion Medicine. Wiley-Blackwell, 2013. 549 p.5. Green A., Hoffbrand A., Catovsky D. et al. Postgraduate Haematology. Wiley-Blackwell, 2011. 1076 p.Green A., Hoffbrand A., Catovsky D. et al. Postgraduate Haematology. Wiley-Blackwell, 2011. 1076 p.6. Landau M., Rosenberg N. Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders. TransfusionLandau M., Rosenberg N. Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders. Transfusion2011;51:558–69.;51:558–69.7. Gouttefangeas C., Diehl M., Keilholz W. Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxity in vitro. Blood 2000;95(10):3168–75.Gouttefangeas C., Diehl M., Keilholz W. Thrombocyte HLA molecules retain nonrenewable endogenous peptides of megakaryocyte lineage and do not stimulate direct allocytotoxity in vitro. Blood 2000;95(10):3168–75.8. Kao K.J., Scornik J.C., McQueen C.F. Evalution of individual spesificities of class I HLA on platelet by a new developed monoclonal antibody. Hum Immunology 1990;27(4):285–97.Kao K.J., Scornik J.C., McQueen C.F. Evalution of individual spesificities of class I HLA on platelet by a new developed monoclonal antibody. Hum Immunology 1990;27(4):285–97.9. Schiffer C.A. Management of alloimmunized, refractory patients in need of platelet transfusions. Vox Sang 1997;73:197–8.Schiffer C.A. Management of alloimmunized, refractory patients in need of platelet transfusions. Vox Sang 1997;73:197–8.10. Воронина Е.Н., Филипенко М.Л., Сергеевич Д.С. и др. Мембранные рецепоры тромбоцитов: функции и полиморфизм. Вестник ВОГиС 2006;10(3):553–64.Воронина Е.Н., Филипенко М.Л., Сергеевич Д.С. и др. Мембранные рецепоры тромбоцитов: функции и полиморфизм. Вестник ВОГиС 2006;10(3):553–64.11. Bontadibi A., Tazzari P.L., Manfroi S. et al. Human-platelet-antigen and neutrophil-antigen gene frequency in the Italian population determined by polymerase chain reaction with sequence specific primers. Haematologica 2000;85:430.Bontadibi A., Tazzari P.L., Manfroi S. et al. Human-platelet-antigen and neutrophil-antigen gene frequency in the Italian population determined by polymerase chain reaction with sequence specific primers. Haematologica 2000;85:430.12. Мейл Д., Бростофф Дж., Рот Д.Б. и др. Иммунология. М.: Логосфера, 2007. 555 с.Мейл Д., Бростофф Дж., Рот Д.Б. и др. Иммунология. М.: Логосфера, 2007. 555 с.13. Chong B.H. Diagnosis, treatment and pathophysiology of autoimmune trombocytopenias. Crit Rev Oncol Hematol 1995;20(3):271–96.Chong B.H. Diagnosis, treatment and pathophysiology of autoimmune trombocytopenias. Crit Rev Oncol Hematol 1995;20(3):271–96.14. Kickler T. The challenge of platelet alloimmunization: management and prevention. Transfus med rev 1990; 4(4 Suppl. 1):8–18.Kickler T. The challenge of platelet alloimmunization: management and prevention. Transfus med rev 1990; 4(4 Suppl. 1):8–18.15. Мельникова В.Н., Кирьянов Г.Ю., Филиппова О.И. Карантинизация лейкофильтрованных донорских эритроцитов – важное звено в обеспечении инфекционной и иммунологической безопасности гемотрансфузий. Трансфузиол 2007;8(1–2):63.Мельникова В.Н., Кирьянов Г.Ю., Филиппова О.И. Карантинизация лейкофильтрованных донорских эритроцитов – важное звено в обеспечении инфекционной и иммунологической безопасности гемотрансфузий. Трансфузиол 2007;8(1–2):63.16. Tasaku T., Fujiik K., Gotoh K. et.al. Significance of platelet-reactive antibody screening for patients facing frequent platelet transfusions. Immunohematology 2002;18(4):104–8.Tasaku T., Fujiik K., Gotoh K. et.al. Significance of platelet-reactive antibody screening for patients facing frequent platelet transfusions. Immunohematology 2002;18(4):104–8.17. Allen D., Samon J., Benjamin S. et al. Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunization. Transfusion Med 2004;14:409–17.Allen D., Samon J., Benjamin S. et al. Survey of the use and clinical effectiveness of HPA-1a/5b-negative platelet concentrates in proven or suspected platelet alloimmunization. Transfusion Med 2004;14:409–17.18. Lin S., Lo S., Lib D. Anti-platelet antibodies in multiply transfused patients. Vox Sang 2002;83(2):242.Lin S., Lo S., Lib D. Anti-platelet antibodies in multiply transfused patients. Vox Sang 2002;83(2):242.19. Головкина Л.Л., Зотиков Е.А. Аллоиммунизация к антигенам систем НРА и HLA у гематологических больных с множественными трансфузиями компонентов крови. Новое в трансфузиологии2003;34:12–22.Головкина Л.Л., Зотиков Е.А. Аллоиммунизация к антигенам систем НРА и HLA у гематологических больных с множественными трансфузиями компонентов крови. Новое в трансфузиологии2003;34:12–22.20. Масчан А.А., Румянцев А.Г. Иммунноопосредованные тромбоцитопении новорожденных: дифференциальный диагноз и принципы терапии. Вопр гематол/онкол и иммунопатол в педиатрии 2010;9(3):3–7.Масчан А.А., Румянцев А.Г. Иммунноопосредованные тромбоцитопении новорожденных: дифференциальный диагноз и принципы терапии. Вопр гематол/онкол и иммунопатол в педиатрии 2010;9(3):3–7.21. Kaplan C. Neonatal Alloimmune Thrombocytopenia: a 50-year story. Immunohematol 2007;23(1):9–13.Kaplan C. Neonatal Alloimmune Thrombocytopenia: a 50-year story. Immunohematol 2007;23(1):9–13.22. Muniz-Diaz E. Diagnostic evaluation of FNAIT. ISBT Science Series 2007;2:48–55.Muniz-Diaz E. Diagnostic evaluation of FNAIT. ISBT Science Series 2007;2:48–55.23. Husebekk A., Kjaer Kilie M., Kjeldsen-Kragh J. et al. Screening of anti- HPA-1a antibodies in HPA-1a-negative mothers. Science Series 2007;2:111–3.Husebekk A., Kjaer Kilie M., Kjeldsen-Kragh J. et al. Screening of anti- HPA-1a antibodies in HPA-1a-negative mothers. Science Series 2007;2:111–3.24. Husebekk A., Skogen B., Kilie M.K. et al. Foetal and neonatal alloimmune thrombocytopenia (FNAIT). ISBT Science Series 2011;6:261–4.Husebekk A., Skogen B., Kilie M.K. et al. Foetal and neonatal alloimmune thrombocytopenia (FNAIT). ISBT Science Series 2011;6:261–4.25. Loewenthal R., Rosenberg N., Kalt R. et al. Compound heterozygosity of HLADRB3* 01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia. TransfusionLoewenthal R., Rosenberg N., Kalt R. et al. Compound heterozygosity of HLADRB3* 01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia. Transfusion2013;53:344–52.;53:344–52.26. Davoren A., Curtis B.R., Aster R.H. et al. Human platelet antigen-specific alloantibodies in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004;44:1220–5.Davoren A., Curtis B.R., Aster R.H. et al. Human platelet antigen-specific alloantibodies in 1162 cases of neonatal alloimmune thrombocytopenia. Transfusion 2004;44:1220–5.27. Davonen A., Smith G., Lucas G. et al. Neonatal alloimmune thrombocytopenia due to HPA-3a antibodies: a case report. Immunohematology 2002;18(Suppl. 2): 33–6.Davonen A., Smith G., Lucas G. et al. Neonatal alloimmune thrombocytopenia due to HPA-3a antibodies: a case report. Immunohematology 2002;18(Suppl. 2): 33–6.28. Foxcoft Z. Intrauterine death involving fetomaternal alloimmune thrombocytopenia due to HPA 5a antibodies. Vox Sang 2004;87(3):133.Foxcoft Z. Intrauterine death involving fetomaternal alloimmune thrombocytopenia due to HPA 5a antibodies. Vox Sang 2004;87(3):133.29. Peterson J.A., Balthazor S.M., Curtis B.R. et al. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b is an important cause of neonatal alloimmune thrombocytopenia. Transfusion 2005;45:1487–95.Peterson J.A., Balthazor S.M., Curtis B.R. et al. Maternal alloimmunization against the rare platelet-specific antigen HPA-9b is an important cause of neonatal alloimmune thrombocytopenia. Transfusion 2005;45:1487–95.30. Marin L., Torio A., Muro M. et al. Alloimmune neonatal neutropenia and thrombocytopenia associated with maternal anti HNA-1a, HPA-3b, HLA antibodies. Pediatr/Allergy/Immunol 2005;16:279–82.Marin L., Torio A., Muro M. et al. Alloimmune neonatal neutropenia and thrombocytopenia associated with maternal anti HNA-1a, HPA-3b, HLA antibodies. Pediatr/Allergy/Immunol 2005;16:279–82.31. Shehata N., Tinmouth A., Naglie G. et al. AB0-identical versus nonidentical platelet transfusion: a systematic review. Transfusion 2009;49(11):2442–53.Shehata N., Tinmouth A., Naglie G. et al. AB0-identical versus nonidentical platelet transfusion: a systematic review. Transfusion 2009;49(11):2442–53.32. Moolten D. Group 0 red blood cells in massive transfusion-when to pull the switch? Immunohematology 2008;24(3):116–8.Moolten D. Group 0 red blood cells in massive transfusion-when to pull the switch? Immunohematology 2008;24(3):116–8.33. Allen D., Ouwehand M., Kekomaki R. et al. Interlaboratory variation in the detection of HPA-specific alloantibodies and in molecular HPA typing. Vox Sang 2007;93:316–24.Allen D., Ouwehand M., Kekomaki R. et al. Interlaboratory variation in the detection of HPA-specific alloantibodies and in molecular HPA typing. Vox Sang 2007;93:316–24.34. Bertrand G., Drame G., Martageix C. et al. Prediction of the fetal status in non-invasive management of alloimmune thrombocytopenia. Blood 2010;10:1182.Bertrand G., Drame G., Martageix C. et al. Prediction of the fetal status in non-invasive management of alloimmune thrombocytopenia. Blood 2010;10:1182.35. Nance S., Hsu S., Vassallo R. et al. Review: Platelet matching for alloimmunezed patients – room for improvement. Immunohematology 2004;20(2):80–8.Nance S., Hsu S., Vassallo R. et al. Review: Platelet matching for alloimmunezed patients – room for improvement. Immunohematology 2004;20(2):80–8.36. VeldhuisenB., van der Schoot C.E., Haas M. Blood group genotyping:from patient to high-throughput donor screening. Vox Sang 2009;97:198–206.VeldhuisenB., van der Schoot C.E., Haas M. Blood group genotyping:from patient to high-throughput donor screening. Vox Sang 2009;97:198–206.37. Metcalfe P., Waters A.H. HPA-1 typing by PCR amplification with sequence-specific primers (PCR-SSP): a rapid and simple technique. Br J Haematol 1993;85:227–31.Metcalfe P., Waters A.H. HPA-1 typing by PCR amplification with sequence-specific primers (PCR-SSP): a rapid and simple technique. Br J Haematol 1993;85:227–31.38. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988;16:1215–8.Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988;16:1215–8.39. Gavanagh G., Dunn A.N., Chapman C.T. HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations. Transfusion Med1997;7:41–5.Gavanagh G., Dunn A.N., Chapman C.T. HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations. Transfusion Med1997;7:41–5.40. Panzer S. Report on the Tenth International Platelet Genotyping and Serology Workshop on behalf of the International Society of Blood Transfusion. Vox Sang 2001;80:72–8.Panzer S. Report on the Tenth International Platelet Genotyping and Serology Workshop on behalf of the International Society of Blood Transfusion. Vox Sang 2001;80:72–8.41. Li R., Pei B., Li Q. Multicolor real-time polymerase chain reaction genotyping of six human platelet antigens using displacing probes. Transfusion 2007;47:1637–42.Li R., Pei B., Li Q. Multicolor real-time polymerase chain reaction genotyping of six human platelet antigens using displacing probes. Transfusion 2007;47:1637–42.42. Ёлов А.А., Бурылёв В.В., Минеева Н.В. и др. Типирование антигенов тромбоцитов методом ПЦР в реальном времени. Молекулярная диагностика. Сб трудов VII всерос науч.-практич. конфер с международным участием 2010;III:60–1.Ёлов А.А., Бурылёв В.В., Минеева Н.В. и др. Типирование антигенов тромбоцитов методом ПЦР в реальном времени. Молекулярная диагностика. Сб трудов VII всерос науч.-практич. конфер с международным участием 2010;III:60–1.43. Ёлов А.А., Лихонин А.Г. Генотипирование ДНК доноров и реципиентов крови как метод обеспечения антигенной безопасности трансфузий. Трансфузиол 2009;10(1–2):33.Ёлов А.А., Лихонин А.Г. Генотипирование ДНК доноров и реципиентов крови как метод обеспечения антигенной безопасности трансфузий. Трансфузиол 2009;10(1–2):33.44. Mинеева Н.В., Ёлов А.А., Бурылёв В.В. и др. Типирование антигенов тромбоцитов доноров и Пациентов методом ПЦР в реальном времени. Трансфузиол 2011;12:62.Mинеева Н.В., Ёлов А.А., Бурылёв В.В. и др. Типирование антигенов тромбоцитов доноров и Пациентов методом ПЦР в реальном времени. Трансфузиол 2011;12:62.45. Shibata Y., Juji T., Nishizawa Y. et al. Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang 1981;41(1):25–31.Shibata Y., Juji T., Nishizawa Y. et al. Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang 1981;41(1):25–31.46. Nguyen X., Dugrillon A., Beck C. et al. Novel method for simultaneous analysis of specific platelet antibodies: SASPA. Br J Haematol 2004;127(5):552–60.Nguyen X., Dugrillon A., Beck C. et al. Novel method for simultaneous analysis of specific platelet antibodies: SASPA. Br J Haematol 2004;127(5):552–60.47. Meyer O., Agaylan A., Bombard S. et al. Novel antigen-specific capture assay for the detection of platelet antibodies and HPA-1a phenotyping. Vox Sang 2006;91:324–30.Meyer O., Agaylan A., Bombard S. et al. Novel antigen-specific capture assay for the detection of platelet antibodies and HPA-1a phenotyping. Vox Sang 2006;91:324–30.48. Kaplan C., Freedman J., Foxcroft Z. et al. Monoclonal platelet antigen capture assays (MAIPA) and reagents: a statement. Vox Sang 2007;93:298–9.Kaplan C., Freedman J., Foxcroft Z. et al. Monoclonal platelet antigen capture assays (MAIPA) and reagents: a statement. Vox Sang 2007;93:298–9.49. Sachs U.J., Kiefel V., Kroll H. et al. Report on the 15th International Society of Blood Transfusion platelet immunology workshop. Vox Sang 2012;103:343–52.Sachs U.J., Kiefel V., Kroll H. et al. Report on the 15th International Society of Blood Transfusion platelet immunology workshop. Vox Sang 2012;103:343–52.50. Hezard N., Simon G., Mace C. et al. Is flow cytometry accurate enough to screen platelet autoantibodies? Transfusion 2008;48:513–8.Hezard N., Simon G., Mace C. et al. Is flow cytometry accurate enough to screen platelet autoantibodies? Transfusion 2008;48:513–8.51. Lucas G., Culliford S., Green A. et al. Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation. Transfusion 2010;50:334–9.Lucas G., Culliford S., Green A. et al. Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation. Transfusion 2010;50:334–9.52. Ghevaert C., Wilcox D.A., Fang J. et al. Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. J Clin Invest 2008;118(8):2929–38.Ghevaert C., Wilcox D.A., Fang J. et al. Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. J Clin Invest 2008;118(8):2929–38.53. Fontão-Wendel R., Silva L., Saviolo C. et al. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assay for the detection of human leukocyte antigen and human platelet antigen antibodies. Vox Sang 2007;93(3):241–9.Fontão-Wendel R., Silva L., Saviolo C. et al. Incidence of transfusion-induced platelet-reactive antibodies evaluated by specific assay for the detection of human leukocyte antigen and human platelet antigen antibodies. Vox Sang 2007;93(3):241–9.